LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease

Atherosclerosis

Volumn 161, Issue 2, 2002, Pages 447-453

  Sposito, Andrei C ^a   Santos, Raul D ^a   Hueb, Whady ^a   Ventura, Laura I ^a   Vinagre, Carmen C G ^a   Ramires, Jose A F ^a   Maranhão, Raul C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apolipoprotein B; Chylomicron; LDL; Metabolism; Remnant

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CARBON 14; CHOLESTEROL; CHOLESTEROL ESTER; CHOLESTEROL OLEATE; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID EMULSION; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL; TRIOLEIN; TRITIUM;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; FEMALE; HUMAN; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOISOTOPE DECAY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEINS B; CHOLESTEROL, LDL; CHYLOMICRONS; COHORT STUDIES; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PROBABILITY; RISK ASSESSMENT; RISK FACTORS;

EID: 0036121117     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00661-X     Document Type: Article

References (45)

1. A receptor-mediated pathway for cholesterol homeostasis
2. Metabolic basis of hyperapobetalipoproteinemia: Turnover of apolipoprotein B in low-density lipoprotein and its precursor and subfractions compared with normal and familial hypercholesterolemia
3. Binding of rat chylomicrons and their remnants to the hepatic low-density-lipoprotein receptor and its role in remnant removal
4. Role of low density lipoprotein receptor-dependent and -independent sites in binding and uptake of chylomicron remnants in rat liver
5. Membrane binding sites for plasma lipoproteins on endosomes from rat liver
6. Lipoprotein clearance mechanisms in LDL receptor-deficient 'Apo-B48-only' and 'Apo-B100-only' mice
7. Hepatic uptake of chylomicron remnants in WHHL rabbits: A mechanism genetically distinct from the low density lipoprotein receptor
8. Effect of the 39-kDa receptor- associated protein on the hepatic uptake and endocytosis of chylomicron remnants and low density lipo-proteins in the rat
9. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist
10. Inducible inactivation of hepatic LRP gene by Cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants
11. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor
12. Metabolism of protein-free lipid emulsion models of chylomicrons in rats
13. Effects of cholesterol content on the metabolism of protein-free emulsion models of lipoproteins
14. Competition between chylomicrons and their remnants for plasma removal: A study with artificial emulsion models of chylomicrons
15. Simultaneous measurements of chylomicron and remnant removal using a doubly labeled artificial lipid emulsion: Studies in normolipidemic and hyperlipidemic subjects
16. Estimation of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge
17. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease
18. Different patterns of postprandial lipoprotein metabolism is normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil
19. A quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B48 and B-100
20. Contribution of apo B-48 and apo B-100 triglyceride-rich lipoproteins (TLR) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters
21. Clearance from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man
22. Effects of particle size and number on the plasma clearance of chylomicrons and remnants
23. Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease
24. The effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia
25. Malignant hypertension is accompanied by marked alterations in chylomicron metabolism
26. Chylomicron metabolism in patients submitted to cardiac transplantation
27. Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver
28. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor
29. Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apo E-deficient mice: Evidence for slow metabolism via an alternative apo E- dependent pathway
30. Receptor and non-receptor mediated uptake of chylomicron remnants by the liver
31. Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL-receptor versus hepatic remnant receptor in vivo
32. Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygous with defined receptor defects
33. Accumulation of chylomicron remnants in homozygous subjects with familial hypercholesterolaemia
34. Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia
35. Effect of pravastatin on removal of plasma from a chylomicron-like emulsion in men with coronary artery disease
36. Chylomicron-like emulsion removal is related to the plasma LDL cholesterol in patients with type IIa dyslipidemia
37. Overexpression of hepatic lipase in transgenic mice rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins
38. Remnant lipoprotein metabolism: Key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E
39. Postprandial lipaemia in familial hypercholesterolaemia: Clinical and metabolic significance
40. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease
41. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: Case control study over three years
42. Postprandial lipoproteins and progression of coronary atherosclerosis
43. Chylomicrons and chylomicron remnants in coronary artery disease: A case-control study
44. Postprandial lipoprotein metabolism in normolipidemic man with and without coronary artery disease